Picodya’s B-Matrix™ technology receives IIA support

01.08.2019

Picodya Technologies Ltd. receives approval for its second program in collaboration with the Israeli Innovation Authority, which has agreed to provide financial support for a sequential development program focused on the company’s groundbreaking B-Matrix™ technology for point-of-care immunoassay diagnostics.

Picodya’s team with IIA Management during a visit at Picodya's headquarters after 2nd program and grant approved by IIA. 19.12.2019 Picodya, Rehovot Isreal

Picodya’s team with IIA Management during a visit at Picodya’s headquarters after 2nd program and grant approved by IIA. 19.12.2019 Picodya, Rehovot Isreal

>> IIA on Facebook

Contact Us

If you’re interested in Picodya and learning more about our game-changing B-Matrix™ technology, simply enter your details below. We’ll be happy to share further details and discuss our vision for better, cheaper, more accessible diagnostics worldwide.